Kyung-Bok Son

Scopus Author ID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 24

Top Topics

Low Density Lipoprotein

Health Insurance

Psychometric Properties

Top Venues

Health economics review

Expert review of pharmacoeconomics & outcomes research

Globalization and health

International journal of health services : planning, administration, evaluation

This page only lists publications with an associated author ORCID identifier.

Publications

Kyung-Bok Son
Public value judgments about the criteria for reimbursement of medicines in South Korea. Expert review of pharmacoeconomics & outcomes research (2024)
Kyung-Bok Son
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea. Health economics review 14 (1) (2024)
Kyung-Bok Son
Public value judgments about the criteria for reimbursement of medicines in South Korea. Expert review of pharmacoeconomics & outcomes research (2024)
Kyung-Bok Son
Which factor reduces pharmaceutical expenditure, number of entrants or price variance? Updated generic drug markets in South Korea. Health economics review 14 (1) (2024)
Kyung-Bok Son
The impact of COVID-19 on the number of active small primary care businesses by severity of the pandemic: evidence from South Korea. BMC primary care 23 (1) (2022)
Kyung-Bok Son, Eui-Kyung Lee
Importance of a usual source of care in choosing low-priced generic drugs: a cross-sectional study. Family practice 39 (5) (2022)
Nahye Choi, Kyung-Bok Son, Joonsoo Byun, Dong-Wook Yang
Perceived impact of the patent linkage system on pharmaceutical market from the viewpoint of the domestic manufacturers in South Korea. Globalization and health 18 (1) (2022)
Kyung-Bok Son
Patenting and patent challenges in South Korea after introducing a patent linkage system. Globalization and health 18 (1) (2022)
Kyung-Bok Son
Understanding long-listed pharmaceutical products without competition in South Korea: policy implications in managing generic entrants and pharmaceutical expenditures. Expert review of pharmacoeconomics & outcomes research (2021)
Kyung-Bok Son
Is greater generic competition also linked to lower drug prices in South Korea? Health economics review 10 (1) (2020)
Kyung-Bok Son
The speed of adoption of new drugs and prescription volume after the amendments in reimbursement coverage: the case of non-vitamin K antagonist oral anticoagulants in South Korea. BMC public health 20 (1) (2020)
Bookyoung Kim, Kyung-Bok Son
Factors affecting the self-rated health of immigrant women married to native men and raising children in South Korea: a cross-sectional study. BMC women's health 20 (1) (2020)
Kyung-Bok Son
Do Free Trade Agreements Matter to Drug Lag? Recent Evidence From Korea After the Korea-U.S. Free Trade Agreement. International journal of health services : planning, administration, evaluation 50 (2) (2020)
Kyung-Bok Son
Understanding the trends in international agreements on pricing and reimbursement for newly marketed medicines and their implications for access to medicines: a computational text analysis. Globalization and health 16 (1) (2020)
Jinhee Kim, Donghwan Lee, Kyung-Bok Son, Seung Jin Bae
The Burden of Cervical Cancer in Korea: A Population-Based Study. International journal of environmental research and public health 17 (17) (2020)
Kyung-Bok Son, SeungJin Bae, Tae-Jin Lee
Does the Patent Linkage System Prolong Effective Market Exclusivity? Recent Evidence From the Korea-U.S. Free Trade Agreement in Korea. International journal of health services : planning, administration, evaluation 49 (2) (2019)
Kyung-Bok Son, Seungmi Choi, Daewon Kim
Public perceptions of the roles and functions of community pharmacies in the era of expanding scopes of pharmaceutical practice: A questionnaire survey in South Korea. Health & social care in the community 27 (4) (2019)
Kyung-Bok Son
Importance of the intellectual property system in attempting compulsory licensing of pharmaceuticals: a cross-sectional analysis. Globalization and health 15 (1) (2019)
Kyung-Bok Son, Seung Jin Bae
Patterns of statin utilisation for new users and market dynamics in South Korea: a 13-year retrospective cohort study. BMJ open 9 (3) (2019)
Kyung-Bok Son
Generic atorvastatin and rosuvastatin in the South Korean market: time of introduction in relation to manufacturer characteristics. Expert review of pharmacoeconomics & outcomes research 20 (5) (2019)
Kyung-Bok Son
Understanding the adoption of new drugs decided by several stakeholders in the South Korean market: a nonparametric event history analysis. Health economics review 8 (1) (2018)
Kyung-Bok Son, Chang-Yup Kim, Tae-Jin Lee
Understanding of for whom, under what conditions and how the compulsory licensing of pharmaceuticals works in Brazil and Thailand: A realist synthesis. Global public health 14 (1) (2018)
Kyung-Bok Son
How Much Time Before Attempting Compulsory Licensing of Pharmaceuticals? A Non-parametric Event History Model With P-splines. International journal of health services : planning, administration, evaluation 49 (1) (2018)
Kyung-Bok Son, Tae-Jin Lee
The trends and constructive ambiguity in international agreements on intellectual property and pharmaceutical affairs: Implications for domestic legislations in low- and middle-income countries. Global public health 13 (9) (2017)